- Reports: Bill to extend federal regulations for compounding pharmacies expected to pass House, Senate
- NPD Group: SPF 30+ fueling sales of skin care products
- Federal government should take wise approach to compounding regulations
- Study: Whooping cough vaccine may not prevent infection
- Sunscreen Bands to drive reapplication
NEW YORK — W.S. Badger Co. has announced that it is voluntarily recalling all lots of its 4-oz. SPF 30 Baby Sunscreen Lotion and one lot of its 4-oz. SPF 30 Kids Sunscreen Lotion due to microbial contamination.
“All of these lots passed the required microbiological and comprehensive challenge testing prior to sale. It was during routine re-testing that we discovered that the preservative system in several lots had been compromised. In our 18-year history, this voluntary recall is a first. We continue to conduct rigorous testing and are taking steps to ensure this doesn’t happen in the future,” stated Badger founder and CEO Bill Whyte.
The products were tested and found to be contaminated with Pseudomonas aeruginosa, Candida parapsilosis and Acremonium fungi. No adverse reactions have been reported in connection with these products, the company stated. Both sunscreens are sold in the United States and Canada online and at major retailers, as well as at independent food co-ops and pharmacies. This product can be identified by matching the UPC with the Lot code, which can be found on the top front of the tube crimp. The company began shipping the recalled lots to stores and individuals as early as February 2013. The affected lots include the following:
- SPF 30 Baby Sunscreen Lotion 4oz (UPC: 634084490091&634084490114) Lot No.s 3024A, 3057B, 3063A, 3063B, 3132A, 3133A
- SPF 30 Kids Sunscreen Lotion (UPC: 634084490145 & 634084490169) Lot No. 3164A
Consumers who have purchased the SPF 30 Baby Sunscreen Lotion should not use these products and may return product to the original point of purchase for a full refund, or contact Badger directly at 1 (800) 603-6100 or email firstname.lastname@example.org between the hours of 8:30 a.m. and 4:30 p.m., ET, Monday through Friday, the company stated. Adverse events that may be related to the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting Program.